Comparative study of the effect of oral liquid therapy with intravenous fluid therapy on the adequacy of renal function after Angiography and Angioplasty

Comparative study of the effect of oral liquid therapy with intravenous fluid therapy on the adequacy of renal function after angiography and angioplasty

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20181122041722N1

Enrollment

120

Registered

2018-12-15

Start date

2018-12-03

Completion date

Unknown

Last updated

2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: angiography. Condition 2: Angioplasty. Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

Interventions

Intervention 1: Intervention group:Oral fluid therapy in patients undergoing angiography and angioplasty. Intervention 2: Control group:Venous fluid therapy in patients undergoing angiography and angi

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients with EF more than 35%. Creatinine is less than 1.5. Patients who do not have ESRD and do not undergo dialysis. Patients with stable hemodynamic status and blood pressure greater than 90mmHg. The calculated GFR values are above 30 CC / min / 1.73. Older people are 18 years of age and under 70 years of age.

Exclusion criteria

Exclusion criteria: People who have gastrointestinal illness after consulting a gastroenterologist Patients with kidney problems Patients taking medications that are effective in kidney function.

Design outcomes

Primary

Measure	Time frame
Changes in creatinine before, after angiography, with an increase in cr content of more than 25% of baseline, or more than 0.5 mg / dl of creatinine increase, is considered as an incidence of CIN. Timepoint: Blood creatinine measurements at the beginning of the study (before the intervention) and 48 hours after the intervention. Method of measurement: The blood creatinine test carried out by the Bt4500 device.;Level Of GFR. Timepoint: Before Of Intervention And 48 hours after intervention. Method of measurement: Due to the formula * Cockcroft-Gault.;Level Of EF. Timepoint: Before Of Intervention. Method of measurement: With an electrocardiograph device.;Kidney function adequacy. Timepoint: 48 hours after intervention. Method of measurement: GFR evaluation.	—

Measure

Time frame

Changes in creatinine before, after angiography, with an increase in cr content of more than 25% of baseline, or more than 0.5 mg / dl of creatinine increase, is considered as an incidence of CIN. Timepoint: Blood creatinine measurements at the beginning of the study (before the intervention) and 48 hours after the intervention. Method of measurement: The blood creatinine test carried out by the Bt4500 device.;Level Of GFR. Timepoint: Before Of Intervention And 48 hours after intervention. Method of measurement: Due to the formula * Cockcroft-Gault.;Level Of EF. Timepoint: Before Of Intervention. Method of measurement: With an electrocardiograph device.;Kidney function adequacy. Timepoint: 48 hours after intervention. Method of measurement: GFR evaluation.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactTofighian Tahere

Sabzevar University of Medical Sciences

tofighiyan260@gmail.com+98 51 4401 1096

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026